Centralize, Track and Empower: Facilitating Good Clinical Data Review in Your Clinical Trial
Most companies now heavily scrutinize their clinical-trial data in response to ICH E6 R2 and the impending ICH E6 R3. And yet, despite heavy scrutiny, not all companies approach clinical-trial data review with the same degree of rigor, even though how a company manages its data can significantly impact the success of its clinical trial. Please join us for a...